[Our experience in treating diabetes mellitus with the preparation Minidiab].
55 patients with non-insulin-dependent diabetes mellitus were treated with the new oral drug Minidiab. In 58.2% of the patients the carbohydrate metabolism was influenced. No relation between the immunoreactive insulin increase and the effect of the treatment was found. An extrapancreatic action of the drug is suggested as its hypoglycemic activity.
Tsanev
A
A
Lazarov
G
G
Manolov
D
D
Daskalova
I
I
Kolebinov
N
N
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005913:Glipizide / Q000627:therapeutic use*; D006801:Humans; D007330:Insulin Antibodies / Q000032:analysis; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D013607:Tablets; D013997:Time Factors
D001786:Blood Glucose; D007330:Insulin Antibodies; D013453:Sulfonylurea Compounds; D013607:Tablets; D005913:Glipizide
Nashiiat opit pri lechenie na zakharniia diabet s preparata Minidiab.